What to monitor Track the following metrics to assess whether the levocarnitine addition is providing value: Body composition changes (use DEXA, InBody, or similar if accessible) Energy levels and exercise performance GI symptoms (compare to baseline on tirzepatide alone if possible) Liver function markers (ALT, AST) if baseline values were elevated General well-being and recovery quality If after 8 to 12 weeks the levocarnitine addition has not produced noticeable improvements in energy, exercise performance, or body composition compared to tirzepatide alone, consider adjusting your protocol or switching to a different compound blend
1, 1992, pp
However, as research continues to uncover their potential effects on glutathione levels and oxidative stress, it becomes increasingly important to use them mindfully
Effect size estimates for all between-group comparisons are presented in Supplementary Table S1
Observational studies revealed that both high and low intake of Se is associated with an increased risk of cardiovascular disease (Rayman 2012)
Data published to date including results from a Phase 2 trial published in The New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023) provide early insights into its gastrointestinal tolerability profile
